发布日期：2010-05-21
英文标题：Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
来源：Ann Oncol, 2010, 21(Suppl 5): v65-v69
The crude incidence of gallbladder and extrahepatic biliary cancer (ICD-10: C23–C24) in the European Union is 3.2 and 5.4/100 000 per year for males and females, respectively. Age-adjusted mortality is 1.4 and 1.9/100 000 for males and females, respectively. The incidence of intrahepatic cholangiocarcinoma (ICD-10: C22.1) is increasing and may be estimated as 0.9–1.3 and 0.4–0.7/100 000 for males and females, respectively, as 10–15% of primary liver cancer (ICD-10: C22). In high-risk areas in Europe (south Italy), the incidence is estimated to be up to 4.9–7.4 and 2.9–4.3/ 100 000 for males and females, respectively, and worldwide, e.g. in northeast Thailand, up to 96/100 000.
